Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
Copyright © 2005 Korean Cancer Association
*North Central Cancer Treatment Group, †Gastrointestinal Tract Cooperative Group, ‡Memorial Sloan-Kettering Cancer Center, §European Organisation for Research and Treatment of Cancer, ∥Seoul National University Hospital, ¶5-fluorouracil, **5-fluorouracil/adriamycin, ††5-fluorouracil/adriamycin/mitomycin-C, ‡‡5-fluorouracil/adriamycin/methyl lomustine, §§5-fluorouracil/adriamycin/methotrexate; ∥∥etoposide/adriamycin/cisplatin, ¶¶etoposide/leucovorin/5-fluorouracil, ***epirubicin/cisplatin/5-fluorouracil, †††not significant.
Randomized trials of chemotherapy versus best supportive care in advanced gastric cancer
*response rate, †median survival, ‡quality of life, §5-fluorouracil/adriamycin/methotrexate, ∥best supportive care, ¶5-fluorouracil/epirubicine/methotrexate, **etoposide/leucovorin/5-fluorouracil, ††not available.
Chemotherapeutic agents for advanced gastric cancer
Randomized trials of combination chemotherapy in advanced gastric cancer
*North Central Cancer Treatment Group, †Gastrointestinal Tract Cooperative Group, ‡Memorial Sloan-Kettering Cancer Center, §European Organisation for Research and Treatment of Cancer, ∥Seoul National University Hospital, ¶5-fluorouracil, **5-fluorouracil/adriamycin, ††5-fluorouracil/adriamycin/mitomycin-C, ‡‡5-fluorouracil/adriamycin/methyl lomustine, §§5-fluorouracil/adriamycin/methotrexate; ∥∥etoposide/adriamycin/cisplatin, ¶¶etoposide/leucovorin/5-fluorouracil, ***epirubicin/cisplatin/5-fluorouracil, †††not significant.
Results of selected phase II studies using new agents in advanced gastric cancer
*response rate, †median survival, ‡quality of life, §5-fluorouracil/adriamycin/methotrexate, ∥best supportive care, ¶5-fluorouracil/epirubicine/methotrexate, **etoposide/leucovorin/5-fluorouracil, ††not available.
*North Central Cancer Treatment Group, †Gastrointestinal Tract Cooperative Group, ‡Memorial Sloan-Kettering Cancer Center, §European Organisation for Research and Treatment of Cancer, ∥Seoul National University Hospital, ¶5-fluorouracil, **5-fluorouracil/adriamycin, ††5-fluorouracil/adriamycin/mitomycin-C, ‡‡5-fluorouracil/adriamycin/methyl lomustine, §§5-fluorouracil/adriamycin/methotrexate; ∥∥etoposide/adriamycin/cisplatin, ¶¶etoposide/leucovorin/5-fluorouracil, ***epirubicin/cisplatin/5-fluorouracil, †††not significant.